1. Yuki N, Hartung HP. Guillain-Barré syndrome. N Engl J Med. 2012; 366:2294–304.
Article
2. Silvestri NJ, Wolfe GI. Asymptomatic/pauci-symptomatic creatine kinase elevations (hyperckemia). Muscle Nerve. 2013; 47:805–15.
Article
3. Chahin N, Sorenson EJ. Serum creatine kinase levels in spinobulbar muscular atrophy and amyotrophic lateral sclerosis. Muscle Nerve. 2009; 40:126–9.
Article
4. Ropper AH, Shahani BT. Pain in Guillain-Barré syndrome. Arch Neurol. 1984; 41:511–4.
5. Scott AJ, Duncan R, Henderson L, Jamal GA, Kennedy PG. Acute rhabdomyolysis associated with atypical Guillain-Barré syndrome. Postgrad Med J. 1991; 67:73–4.
6. Hanemann CO, Neuen-Jacob E. Muscle injury in Guillain-Barré syndrome: a case report. J Neurol. 1999; 246:1207–8.
Article
7. Satoh J, Okada K, Kishi T, Nagayama S, Kuroda Y. Cramping pain and prolonged elevation of serum creatine kinase levels in a patient with Guillain-Barré syndrome following Campylobacter jejuni enteritis. Eur J Neurol. 2000; 7:107–9.
Article
8. Saxena A, Singh V, Verma N. Guillain-Barre syndrome complicated by acute fatal rhabdomyolysis. Indian J Crit Care Med. 2014; 18:241–3.
9. Choi SJ, Hong YH, Kim JS, Shin JY, Sung JJ. HyperCKemia in Guillain-Barré syndrome. Eur Neurol. 2020; 83:415–20.
Article
10. Hosokawa T, Nakajima H, Sawai T, Nakamura Y, Sano E, Tsukahara A, et al. Clinical features of Guillain-Barré syndrome patients with elevated serum creatine kinase levels. BMC Neurol. 2020; 20:214.
Article